ICD-10-PCS Procedure Codes in Group XW0
- XW00X27 Introduction of Bromelain-enriched Proteolytic Enzyme into Skin, External Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW01318 Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedur
- XW01329 Introduction of Talquetamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW01348 Introduction of Teclistamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW01397 Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW013F5 Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5 ICD-10-PCS
- XW013G6 Introduction of REGN-COV2 Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Cod
- XW013H6 Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Pr
- XW013K6 Introduction of Leronlimab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Co
- XW013L9 Introduction of Elranatamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW013S6 Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW013S9 Introduction of Epcoritamab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure C
- XW013T6 Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW013U6 Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW013V7 Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW013W5 Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW013W7 Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW01X27 Introduction of Bromelain-enriched Proteolytic Enzyme into Subcutaneous Tissue, External Approach, New Technology Group 7 ICD-10-PCS Procedure
- XW020D8 Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW023S6 Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW023T6 Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW023U6 Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW023V7 Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW023W7 Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW023X7 Introduction of tixagevimab and cilgavimab monoclonal antibody into muscle, percutaneous approach, new technology group 7 ICD-10-PCS Procedure
- XW023Y7 Introduction of other new technology monoclonal antibody into muscle, percutaneous approach, new technology group 7 ICD-10-PCS Procedure Code
- XW03306 Introduction of Brexanolone into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW03308 Introduction of Spesolimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- ABC Medical Services, Remedies, and Supply Codes - Group
- XW03326 Introduction of Nerinitide into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- ABC Medical Services, Remedies, and Supply Codes - Group
- XW03336 Introduction of Durvalumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- ABC Medical Services, Remedies, and Supply Codes - Group
- ABC Medical Services, Remedies, and Supply Codes - Group
- XW03357 Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW03358 Introduction of Mosunetuzumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW03366 Introduction of Lefamulin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW03367 Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW03368 Introduction of Afamitresgene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedur
- XW03372 Introduction of Andexanet Alfa, Factor Xa Inhibitor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 2 ICD-10-
- XW03377 Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW03378 Introduction of Tabelecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW03387 Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW03388 Introduction of Treosulfan into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW03392 Introduction of Defibrotide Sodium Anticoagulant into Peripheral Vein, Percutaneous Approach, New Technology Group 2 ICD-10-PCS Procedure Code
- XW03396 Introduction of Ceftolozane/Tazobactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure
- XW03398 Introduction of Inebilizumab-cdon into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW033A3 Introduction of Bezlotoxumab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 3 ICD-10-PCS Procedure Code
- XW033A6 Introduction of Cefiderocol Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033A7 Introduction of Ciltacabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW033B3 Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 3 ICD-10
- XW033B6 Introduction of Omadacycline Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033B7 Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW033C3 Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technolo
- XW033C6 Introduction of Eculizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033C7 Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technolo
- XW033D6 Introduction of Atezolizumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033E5 Introduction of Remdesivir Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW033E6 Introduction of Etesevimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033F3 Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 3 ICD-10-PCS Proc
- XW033F5 Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Proc
- XW033F6 Introduction of Bamlanivimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033G4 Introduction of Plazomicin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 4 ICD-10-PCS Procedure Code
- XW033G5 Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW033G6 Introduction of REGN-COV2 Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033G7 Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technolo
- XW033H4 Introduction of Synthetic Human Angiotensin II into Peripheral Vein, Percutaneous Approach, New Technology Group 4 ICD-10-PCS Procedure Code
- XW033H5 Introduction of Tocilizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW033H6 Introduction of Other New Technology Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Proced
- XW033H7 Introduction of Axicabtagene Ciloleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure
- XW033J7 Introduction of Tisagenlecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW033K5 Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW033K7 Introduction of Idecabtagene Vicleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure
- XW033K9 Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW033L6 Introduction of CD24Fc Immunomodulator into Peripheral Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW033L7 Introduction of Lifileucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW033M7 Introduction of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedu
- XW033N5 Introduction of Meropenem-vaborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure
- XW033N7 Introduction of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedur
- XW033P9 Introduction of Glofitamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW033Q5 Introduction of Tagraxofusp-erzs Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW033Q9 Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW033R9 Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW033S5 Introduction of Iobenguane I-131 Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW033U5 Introduction of Imipenem-cilastatin-relebactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS P
- XW033W5 Introduction of Caplacizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW04306 Introduction of Brexanolone into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW04308 Introduction of Spesolimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- ABC Medical Services, Remedies, and Supply Codes - Group
- XW04326 Introduction of Nerinitide into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- ABC Medical Services, Remedies, and Supply Codes - Group
- XW04336 Introduction of Durvalumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- ABC Medical Services, Remedies, and Supply Codes - Group
- ABC Medical Services, Remedies, and Supply Codes - Group
- XW04357 Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW04358 Introduction of Mosunetuzumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW04366 Introduction of Lefamulin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW04367 Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW04368 Introduction of Afamitresgene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure C
- XW04372 Introduction of Andexanet Alfa, Factor Xa Inhibitor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 2 ICD-10-PCS
- XW04377 Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW04378 Introduction of Tabelecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW04387 Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW04388 Introduction of Treosulfan into Central Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW04392 Introduction of Defibrotide Sodium Anticoagulant into Central Vein, Percutaneous Approach, New Technology Group 2 ICD-10-PCS Procedure Code
- XW04396 Introduction of Ceftolozane/Tazobactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Co
- XW04398 Introduction of Inebilizumab-cdon into Central Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW043A3 Introduction of Bezlotoxumab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 3 ICD-10-PCS Procedure Code
- XW043A6 Introduction of Cefiderocol Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043A7 Introduction of Ciltacabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW043B3 Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3 ICD-10-
- XW043B6 Introduction of Omadacycline Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043B7 Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW043C3 Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology
- XW043C6 Introduction of Eculizumab into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043C7 Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology
- XW043D6 Introduction of Atezolizumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043E5 Introduction of Remdesivir Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW043E6 Introduction of Etesevimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043F3 Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 3 ICD-10-PCS Procedu
- XW043F5 Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedu
- XW043F6 Introduction of Bamlanivimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043G4 Introduction of Plazomicin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 4 ICD-10-PCS Procedure Code
- XW043G5 Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW043G6 Introduction of REGN-COV2 Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043G7 Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology
- XW043H4 Introduction of Synthetic Human Angiotensin II into Central Vein, Percutaneous Approach, New Technology Group 4 ICD-10-PCS Procedure Code
- XW043H5 Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW043H6 Introduction of Other New Technology Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure
- XW043H7 Introduction of Axicabtagene Ciloleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Co
- XW043J7 Introduction of Tisagenlecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW043K5 Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW043K7 Introduction of Idecabtagene Vicleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Cod
- XW043K9 Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW043L6 Introduction of CD24Fc Immunomodulator into Central Vein, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW043L7 Introduction of Lifileucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW043M7 Introduction of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure
- XW043N5 Introduction of Meropenem-vaborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Cod
- XW043N7 Introduction of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS Procedure C
- XW043P9 Introduction of Glofitamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW043Q5 Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW043Q9 Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW043R9 Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW043S5 Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW043U5 Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Proc
- XW043W5 Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW053T9 Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9 ICD-10-PCS Proced
- XW097M5 Introduction of Esketamine Hydrochloride into Nose, Via Natural or Artificial Opening, New Technology Group 5 ICD-10-PCS Procedure Code
- XW0DX38 Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW0DX66 Introduction of Lefamulin Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW0DX82 Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2 ICD-10-PCS Procedure Code
- XW0DXF5 Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5 ICD-10-PCS Proced
- XW0DXJ5 Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW0DXJ9 Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW0DXK8 Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8 ICD-10-PCS Procedure Code
- XW0DXL5 Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW0DXM6 Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW0DXN9 Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9 ICD-10-PCS Procedure Code
- XW0DXR5 Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW0DXR7 Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7 ICD-10-PCS Procedure Code
- XW0DXT5 Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW0DXV5 Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5 ICD-10-PCS Procedure Code
- XW0G738 Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8 ICD-10-PCS Procedure Code
- XW0G7K8 Introduction of Sabizabulin into Upper GI, Via Natural or Artificial Opening, New Technology Group 8 ICD-10-PCS Procedure Code
- XW0G7M6 Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6 ICD-10-PCS Procedure Code
- XW0G7R7 Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7 ICD-10-PCS Procedure Code
- XW0G886 Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6 ICD
- XW0H738 Introduction of Maribavir Anti-infective into Lower GI, Via Natural or Artificial Opening, New Technology Group 8 ICD-10-PCS Procedure Code
- XW0H7K8 Introduction of Sabizabulin into Lower GI, Via Natural or Artificial Opening, New Technology Group 8 ICD-10-PCS Procedure Code
- XW0H7M6 Introduction of Baricitinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 6 ICD-10-PCS Procedure Code
- XW0H7R7 Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7 ICD-10-PCS Procedure Code
- XW0H7X8 Introduction of Broad Consortium Microbiota-based Live Biotherapeutic Suspension into Lower GI, Via Natural or Artificial Opening, New Technol
- XW0H886 Introduction of Mineral-based Topical Hemostatic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6 ICD
- XW0Q316 Introduction of Eladocagene exuparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 6 ICD-10-PCS Procedure Code
- XW0V0P7 Introduction of Antibiotic-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7 ICD-10-PCS Procedure Code
ICD-10-PCS Procedure Codes - X Group
ICD-10-PCS Procedure Codes
The ICD-10 Procedure Coding System (ICD-10-PCS) is a system of medical classification used for procedural codes. The National Center for Health Statistics (NCHS) received permission from the World Health Organization (WHO), the body responsible for publishing the International Classification of Diseases to create the ICD-10-PCS as a successor to Volume 3 of ICD-9-CM and a clinical modification of the original ICD-10. The final draft was completed in 2000, but the system still has not been implemented, as the WHO has not yet set any anticipated implementation date at which to phase out ICD-9-CM.
The new procedure coding system uses 7 alpha or numeric digits while the ICD-9-CM coding system uses 3 or 4 numeric digits.The current system, International Classification of Diseases, 9th Edition, Clinical Modification (ICD-9-CM), does not provide the necessary detail on either patients' medical conditions or on procedures performed on hospitalized patients. ICD-9-CM is 30 years old, has outdated and obsolete terminology, uses outdated codes that produce inaccurate and limited data, and is inconsistent with current medical practice. It cannot accurately describe the diagnoses and inpatient procedures of care delivered in the 21st century.
Diagnostic Information is Not Included in Procedure Description
When procedures are performed for specific diseases or disorders, the disease or disorder is not contained in the procedure code. There are no codes for procedures exclusive to aneurysms, cleft lip, strictures, neoplasms, hernias, etc. The diagnosis codes, not the procedure codes, specify the disease or disorder.
Not Otherwise Specified (NOS) Options are Restricted
ICD-9-CM often provides a "not otherwise specified" code option. Certain NOS options made available in ICD-10-PCS are restricted to the uses laid out in the ICD-10-PCS draft guidelines. A minimal level of specificity is required for each component of the procedure.
Limited Use of Not Elsewhere Classified (NEC) Option
ICD-9-CM often provides a "not elsewhere classified" code option, but because all significant components of a procedure are specified in ICD-10-PCS, there is generally no need for an NEC code option. However, limited NEC options are incorporated into ICD-10-PCS where necessary. For example, new devices are frequently developed, and therefore it is necessary to provide an "Other Device" option for use until the new device can be explicitly added to the coding system. Additional NEC options are discussed later, in the sections of the system where they occur.
Level of Specificity
All procedures currently performed can be specified in ICD-10-PCS. The frequency with which a procedure is performed was not a consideration in the development of the system. Rather, a unique code is available for variations of a procedure that can be performed.
ICD-10-PCS has a seven character alphanumeric code structure. Each character contains up to 34 possible values. Each value represents a specific option for the general character definition (e.g., stomach is one of the values for the body part character). The ten digits 0-9 and the 24 letters A-H,J-N and P-Z may be used in each character. The letters O and I are not used in order to avoid confusion with the digits 0 and 1.
The second through seventh characters mean the same thing within each section, but may mean different things in other sec-tions.
In all sections, the third character specifies the general type of procedure per-formed (e.g., resection, transfusion, fluoroscopy), while the other characters give additional information such as the body part and approach. In ICD-10-PCS, the term "procedure" refers to the complete specification of the seven characters.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com